BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1431707)

  • 1. A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer.
    Moss SM; Summerley ME; Thomas BT; Ellman R; Chamberlain JO
    J Epidemiol Community Health; 1992 Aug; 46(4):362-4. PubMed ID: 1431707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales.
    Fielder HM; Warwick J; Brook D; Gower-Thomas K; Cuzick J; Monypenny I; Duffy SW
    J Med Screen; 2004; 11(4):194-8. PubMed ID: 15563774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-control Studies on the Effectiveness of Breast Cancer Screening: Insights from the UK Age Trial.
    van der Waal D; Broeders MJ; Verbeek AL; Duffy SW; Moss SM
    Epidemiology; 2015 Jul; 26(4):590-6. PubMed ID: 25767987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.
    Tabar L; Yen MF; Vitak B; Chen HH; Smith RA; Duffy SW
    Lancet; 2003 Apr; 361(9367):1405-10. PubMed ID: 12727392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer.
    Lancet; 1999 Jun; 353(9168):1909-14. PubMed ID: 10371568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia.
    Roder D; Houssami N; Farshid G; Gill G; Luke C; Downey P; Beckmann K; Iosifidis P; Grieve L; Williamson L
    Breast Cancer Res Treat; 2008 Apr; 108(3):409-16. PubMed ID: 18351455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer in East Anglia: the impact of the breast screening programme on stage at diagnosis.
    McCann J; Stockton D; Day N
    J Med Screen; 1998; 5(1):42-8. PubMed ID: 9575460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study.
    Johns LE; Coleman DA; Swerdlow AJ; Moss SM
    Br J Cancer; 2017 Jan; 116(2):246-252. PubMed ID: 27931047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands.
    Paap E; Verbeek A; Puliti D; Broeders M; Paci E
    J Med Screen; 2011; 18(3):142-6. PubMed ID: 22045823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control evaluation of breast cancer screening efficacy.
    Friedman DR; Dubin N
    Am J Epidemiol; 1991 May; 133(10):974-84. PubMed ID: 2035508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: A nested case-control study within a cohort of one million women.
    Johns LE; Swerdlow AJ; Moss SM
    J Med Screen; 2018 Jun; 25(2):76-81. PubMed ID: 28675954
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.